Ani Pharmaceuticals (ANIP) Change in Cash (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Change in Cash of $25.6 million for Q1 2026, up 11.39% sequentially from $23.0 million in Q4 2025, and up 417.83% YoY from $4.9 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Change in Cash (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Change in Cash for 17 years, with the latest figure at $25.6 million in Q1 2026.
- Quarterly Change in Cash rose 417.83% year-over-year to $25.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $161.4 million (up 304.89% YoY) and the FY2025 annual result came in at $140.7 million, up 284.62% from the prior year.
- Change in Cash grew to $25.6 million in Q1 2026 per ANIP's latest filing, from $23.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $94.0 million in Q2 2023 and troughed at -$95.1 million in Q3 2024.
- A 5-year average of $12.1 million and a median of $11.5 million in 2024 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2025: Change in Cash plunged 1567.69% in 2022, then jumped 18778.86% in 2025.
- Over 5 years, Change in Cash stood at -$8.0 million in 2022, then jumped by 448.36% to $28.0 million in 2023, then slumped by 100.44% to -$123000.0 in 2024, then surged by 18778.86% to $23.0 million in 2025, then advanced by 11.39% to $25.6 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $25.6 million, $23.0 million, and $44.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 49.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.04 Mn |
| Mar 31, 2026 | 25.59 Mn |
| Dec 31, 2025 | 22.98 Mn |
| Sep 30, 2025 | 44.81 Mn |
| Jun 30, 2025 | 68.00 Mn |
| Mar 31, 2025 | 4.94 Mn |
| Dec 31, 2024 | -123,000.00 |
| Sep 30, 2024 | -95.09 Mn |
| Jun 30, 2024 | 11.51 Mn |
| Mar 31, 2024 | 7.48 Mn |
| Dec 31, 2023 | 28.04 Mn |
| Sep 30, 2023 | 31.37 Mn |
| Jun 30, 2023 | 93.95 Mn |
| Mar 31, 2023 | 14.52 Mn |
| Dec 31, 2022 | -8.05 Mn |
| Sep 30, 2022 | -7.10 Mn |
| Jun 30, 2022 | -13.53 Mn |
| Mar 31, 2022 | -23.39 Mn |
| Dec 31, 2021 | 85.05 Mn |
| Sep 30, 2021 | -9.01 Mn |